Funded Startups Agent

Deepansh Vashisth

← All reports

Monday, 6 July 2026

Weekly Funded Startups Digest — 2026-07-06

Weekly Funded Startups Digest — 2026-07-06

Coverage window: Prior calendar week, Mon 29 Jun – Sun 5 Jul 2026.

Duplicate rule: Companies already in applications.yaml are omitted unless they rank in the top list for verified deals this week. Newly surfaced companies are appended to applications.yaml.

Source discipline: Funding facts use cited startup news, company press releases, or investor/newswire sources. No contact emails or phone numbers are invented. Outreach drafts are for review only and were not sent.

Week note: India had a healthy early/growth-stage week ($105M+ per Inc42) after CRED's mega-round skewed the prior week. Canada had only two verified Seed–Series B announcements in-window (Stathera Series B, JUDI.AI growth round with undisclosed amount) plus Dominion Dynamics Series A (already surfaced). Digest includes five Canada entries with explicit remote-from-India assessments and two watchlist carries.

Top 3 this week (Slack summary)

  1. Age Care Labs (India) — ₹85 Cr Series B1 eldercare platform (Emoha/Epoch); capital targets tech platform and nationwide service expansion — closest match to HealthPlix clinic-network + care-continuity product work.
  2. MyKare.ai (India) — $1M Series A extension on $3.2M total; AI-native clinic/hospital OS automating patient acquisition through follow-ups — direct healthtech SaaS overlap with 30+ provider customers and global expansion signal.
  3. Kapture CX (India) — $10M pre-Series B agentic enterprise CX SaaS; profitable 4× revenue growth since 2023 Series A and explicit global product scale mandate.

India (10 companies)

1. Age Care Labs

Funding: ₹85 Cr (~$9M) Series B1 — 2 Jul 2026
Source: https://inc42.com/buzz/age-care-labs-raises-%E2%82%B985-cr-to-build-senior-living-communities/
Score: 9.4/10 — healthtech/agetech; tech-platform investment; Shremoha senior-living launch.

What they do:

  • Parent of eldercare brands Emoha and Epoch Elder Care; integrated at-home and community eldercare across India.
  • Series B1 led by Shrem Group with Rainmatter (Zerodha), Pegasus Finvest, and family offices; part of planned ₹250 Cr Series B closing in Q1 2027.
  • Partnering with Shrem Group to launch Shremoha, a premium senior independent-living platform combining wellness, hospitality, and healthcare.

Why hiring now:

  • Fresh capital explicitly earmarked for technology platform strengthening, healthcare capabilities, and nationwide service expansion.
  • Shremoha launch adds new product surface area (residential communities + care services) beyond existing Emoha/Epoch brands.

Role hypothesis: Senior Product Manager - Care Platform, Product Manager - Elder Care Workflows, Product Manager - Senior Living (Shremoha).

Fit thesis: Strongest healthtech match this week. Deepansh's 6 years at HealthPlix scaling clinician workflows to 10K+ users with >95% retention maps directly to Age Care Labs' integrated care platform and specialty workflow expansion. Government partnership experience (Goa) parallels multi-stakeholder eldercare delivery.

Proof points:

  • Launched India's first gynecology-specific EMR 0-to-1 with 10% demo-to-activation improvement.
  • Scaled re-architected platform across 10,000+ doctors in 6 months with specialty workflow reprioritisation (+8% active usage).

Entry path:

  1. Check Age Care Labs / Emoha careers pages and LinkedIn jobs for product roles.
  2. Search LinkedIn for leadership at Age Care Labs and Emoha brand.
  3. Suggested outreach angle: care-continuity productisation from Series C healthtech SaaS background.

Outreach draft:

Hi — congrats on Age Care Labs' ₹85 Cr Series B1 and the Shremoha partnership. I spent 6 years at HealthPlix shipping clinician workflows at scale and launching specialty care modules 0-to-1. Your tech-platform investment and senior-living expansion look like the exact product challenge I want next. Would love to explore PM roles as you scale nationwide.

Risk flags: Series B1 is partial tranche of larger round. Ops/service delivery may absorb early hires before dedicated PM capacity. No public PM job posting verified this week.


2. MyKare.ai

Funding: $1M Series A extension ($3.2M total raised) — 29 Jun 2026
Source: https://entrackr.com/snippets/healthcare-startup-mykareai-raises-32-mn-12117898
Score: 9.2/10 — clinic/hospital AI OS; global expansion; 20+ provider waitlist.

What they do:

  • AI-native healthcare operating system for clinics and hospitals automating patient acquisition, appointments, follow-ups, communication, and feedback via AI agents and voice AI.
  • Founded 2021; serves 30+ hospitals/clinics across India, Middle East, UK, and US with 20+ providers on waitlist.
  • Latest $1M from Papa.com founders Andrew Parker and Alfredo Vaamonde plus a Middle Eastern family office.

Why hiring now:

  • Capital targets AI capability enhancement, product development acceleration, and global market expansion (US oncology chain, UK dental chain, Qatar talks per founder).
  • Waiting list of 20+ providers signals product-market pull requiring roadmap and onboarding scale.

Role hypothesis: Product Manager - Clinic Workflows, Senior Product Manager - Patient Access, Product Manager - Voice AI / Operations.

Fit thesis: Near-perfect domain overlap: B2B healthtech SaaS for clinics with workflow automation, funnel instrumentation, and multi-segment users. Deepansh's HealthPlix experience with doctor onboarding, specialty workflows, and retention mechanics applies directly to MyKare's "10+ disconnected systems" problem for SMB clinics.

Proof points:

  • Conducted 60+ user interviews at HealthPlix; identified specialty workflow gaps driving roadmap reprioritisation.
  • Instrumented funnels with SQL/Mixpanel; surfaced wallet-share concentration informing product decisions.

Entry path:

  1. Check MyKare.ai careers / LinkedIn jobs and Papa.com investor network for intros.
  2. Search LinkedIn for founder Senu Sam and cofounders Rahmathulla T M, Joash Philipose.
  3. Suggested outreach angle: clinic workflow productisation from HealthPlix + Tier 2–3 user insight.

Outreach draft:

Hi Senu — congrats on the latest MyKare.ai funding. I'm a PM who spent 6 years at HealthPlix building clinician-facing workflows and launching specialty modules 0-to-1. Your AI-native clinic OS and global expansion plans mirror problems I've solved at scale. Would love to explore PM opportunities as you onboard your waitlist.

Risk flags: Total raise still modest ($3.2M). Early-stage may prioritize engineering over PM. Global expansion adds compliance complexity.


3. Kapture CX

Funding: $10M pre-Series B — 30 Jun 2026
Source: https://inc42.com/buzz/kapture-cx-bags-10-mn-to-take-its-ai-powered-crm-tools-global/
Score: 8.8/10 — profitable enterprise SaaS; 350+ employees; explicit global product scale.

What they do:

  • Bengaluru-based verticalized agentic AI platform for customer experience; serves 1,000+ enterprises across 18 countries including Bajaj Finance, Tata Group, and Reliance Group companies.
  • Bajaj Finserv Ventures-led pre-Series B with Cactus Partners and India Alternatives; first BFSV investment in AI.
  • Claims 4× revenue growth and profitability since 2023 Series A; targeting 5× revenue growth over next few years.

Why hiring now:

  • Fresh capital for international expansion (North America, Middle East, Southeast Asia), R&D, and product development at 350+ headcount.
  • Enterprise shift from AI experimentation to deployment creates product roadmap pressure for workflow and agentic features.

Role hypothesis: Senior Product Manager - Agentic AI, Product Manager - Enterprise CX Workflows, Product Manager - Global Expansion.

Fit thesis: Deepansh's B2B SaaS shipping at scale, SQL/funnel analytics, and cross-functional delivery (100+ critical fixes) translate to Kapture's enterprise workflow problem. Investor-facing product storytelling during HealthPlix Series C adds credibility for enterprise sales cycles.

Proof points:

  • Collaborated with CEO on product walk-throughs with 15+ investors during HealthPlix Series C ($22M).
  • Shipped platform re-architecture scaling to 10,000+ doctors with >95% retention.

Entry path:

  1. Check Kapture CX careers page and LinkedIn jobs (Bengaluru HQ with US/Singapore/UAE offices).
  2. Search LinkedIn for cofounder & CEO Sheshgiri Kamath.
  3. Suggested outreach angle: enterprise workflow PM from healthtech SaaS with analytics depth.

Outreach draft:

Hi Sheshgiri — congrats on Kapture's pre-Series B led by Bajaj Finserv Ventures. I'm a B2B SaaS PM from HealthPlix with 6 years shipping enterprise workflows, funnel analytics (SQL/Mixpanel), and investor-facing product narratives during our Series C. Your global agentic CX scale mission looks compelling — would love to explore PM roles.

Risk flags: Enterprise AI is crowded. Profitability may mean leaner hiring than hypergrowth peers. No verified PM posting this week.


4. Supply6

Funding: ₹48 Cr (~$5M) Series A — 1 Jul 2026
Source: https://entrackr.com/snippets/nutrition-startup-supply6-raises-rs-48-cr-led-by-unilever-ventures-12122813
Score: 8.5/10 — consumer D2C nutrition; Unilever Ventures; explicit product/engineering hiring.

What they do:

  • Bengaluru D2C nutrition brand simplifying daily supplements; ₹75 Cr ARR targeting ₹100 Cr in 3–4 months.
  • Unilever Ventures-led Series A with Zeropearl VC and actor-entrepreneur Kriti Sanon; prior $1.1M seed (Sep 2025).
  • Plans product range expansion, clinical research, supply chain scale, and D2C/quick-commerce/retail growth.

Why hiring now:

  • Company stated four priorities including "deepening product and engineering investment" and "growing the team across functions."
  • Unilever Ventures backing signals CPG-grade product and GTM expectations.

Role hypothesis: Product Manager - Consumer Nutrition, Senior Product Manager - D2C Growth, Product Manager - Quick Commerce / Retention.

Fit thesis: Consumer-first product with growth mechanics aligns with Deepansh's refer-and-earn loop (15% lead volume, 90% junk reduction) and psychology background. Clinical research investment parallels regulated health product thinking from HealthPlix.

Proof points:

  • Designed refer-and-earn growth loop end-to-end — 15% additional monthly lead volume, 90% reduction in junk leads.
  • SceneDrop side project: qualitative research (7 interviews + 35-user survey) driving product concept for consumer engagement.

Entry path:

  1. Check Supply6 careers / LinkedIn jobs and Unilever Ventures portfolio.
  2. Search LinkedIn for Supply6 founders/leadership.
  3. Suggested outreach angle: consumer growth PM with health-adjacent D2C and research depth.

Outreach draft:

Hi — congrats on Supply6's Unilever Ventures-led Series A. I'm a PM with consumer growth experience (refer-and-earn loops, funnel analytics) and a healthtech background from HealthPlix. Your clinical research + D2C expansion plans look like a strong product challenge — would love to explore PM roles.

Risk flags: D2C nutrition is competitive. CPG investors may prioritize brand/marketing hires early. ARR claims are company-stated.


5. The Indus Valley

Funding: $17M Series B — 30 Jun 2026
Source: https://economictimes.indiatimes.com/tech/funding/toxin-free-cookware-brand-the-indus-valley-raises-17-million-funding-led-by-gaja-capital/articleshow/132076919.cms
Score: 8.2/10 — scaled D2C consumer brand (₹200 Cr ARR); omnichannel expansion.

What they do:

  • Chennai-based toxin-free cookware D2C brand (cast iron, stainless steel, triply) founded 2016; ₹200 Cr ARR targeting ₹1,000 Cr by 2030.
  • Gaja Capital-led Series B with DSG Consumer Partners, Rukam Capital, and The Chennai Angels.
  • Capital for category expansion, omnichannel distribution (modern + general trade), and brand marketing.

Why hiring now:

  • Series B at scale typically adds product, supply chain, and growth leadership as offline retail footprint expands.
  • Category expansion beyond core cookware creates new SKU and journey product problems.

Role hypothesis: Product Manager - Omnichannel Experience, Senior Product Manager - Consumer D2C, Product Manager - Category Expansion.

Fit thesis: Deepansh's consumer psychology lens, Tier 2–3 field insight, and growth loop design apply to premiumisation-driven D2C scaling. Less direct healthtech overlap but strong consumer PM fit.

Proof points:

  • Tier 2–3 field sales background unlocking 20+ geographies and 1,000+ doctor relationships — translates to distribution insight.
  • Next Workout marketplace side project: 70+ screens separating user intents into distinct booking flows.

Entry path:

  1. Check The Indus Valley careers / LinkedIn jobs.
  2. Search LinkedIn for cofounder & CEO Jagadeesh Kumar.
  3. Suggested outreach angle: omnichannel consumer product from research + growth background.

Outreach draft:

Hi Jagadeesh — congrats on The Indus Valley's $17M Series B. I'm a PM with consumer research depth and field insight across Tier 2–3 India, plus D2C marketplace product work. Your omnichannel expansion and category growth look compelling — would love to explore product roles.

Risk flags: Series B D2C may prioritize ops/supply chain over PM. Cookware category less aligned with healthtech preference. Secondary component in round.


6. Data Science Wizards

Funding: $5M pre-Series A — 1 Jul 2026
Source: https://entrackr.com/snippets/data-science-wizards-raises-5-mn-in-pre-series-a-round-12122203
Score: 7.9/10 — enterprise AI platform (UnifyAI OS); US expansion mandate.

What they do:

  • Mumbai enterprise AI startup building UnifyAI OS for governed, scalable AI deployment across regulated industries.
  • Angel-led pre-Series A; prior $1.4M seed (Oct 2024) at $16.4M valuation.
  • Proceeds for product innovation, North American operations, engineering and customer success expansion.

Why hiring now:

  • Explicit plans to expand engineering organization and scale UnifyAI OS adoption in enterprise/regulated sectors.
  • US expansion creates product localisation and enterprise workflow requirements.

Role hypothesis: Product Manager - Enterprise AI Platform, Senior Product Manager - Regulated Industries, Product Manager - US Market.

Fit thesis: B2B platform workflow experience from HealthPlix applies to enterprise AI governance surfaces. SQL/analytics and cross-functional shipping translate; domain is less consumer/health but SaaS PM skills transfer.

Proof points:

  • Instrumented funnels with SQL and Mixpanel at HealthPlix; data-driven roadmap reprioritisation.
  • Government of Goa partnership — experience with regulated/stakeholder-heavy deployments.

Entry path:

  1. Check Data Science Wizards careers / LinkedIn jobs.
  2. Search LinkedIn for founder & CEO Sandeep Khuperkar.
  3. Suggested outreach angle: enterprise workflow PM from regulated healthtech SaaS.

Outreach draft:

Hi Sandeep — congrats on DSW's $5M pre-Series A. I'm a B2B SaaS PM from HealthPlix with experience shipping governed workflows for clinicians and scaling platform adoption. Your UnifyAI OS expansion into regulated industries looks like a strong fit — would love to explore PM roles.

Risk flags: Investors undisclosed in some reports. Enterprise AI platform space is crowded. Mumbai HQ; remote policy unverified.


7. The Func. Lab

Funding: $1.5M Seed — 29 Jun 2026
Source: https://www.businessoffood.in/the-func-lab-secures-1-5-m-seed-round-to-build-indias-clean-label-nutrition/
Score: 7.6/10 — consumer D2C functional nutrition; strategic angel syndicate; omnichannel scale.

What they do:

  • Clean-label electrolyte and functional nutrition D2C brand; launched Jul 2025 with presence across D2C, e-commerce, quick-commerce, and offline retail.
  • Seed from strategic angels including Nisaba Godrej (Godrej Consumer), Anand Piramal, Harsh Parekh (PharmEasy), Bhakti Modi (Tira), and others.
  • Capital for product innovation, distribution expansion, and supply chain strengthening.

Why hiring now:

  • Early-stage brand scaling across quick-commerce and retail channels after ~11 months of market presence.
  • PharmEasy-connected investor signals health-adjacent distribution expertise.

Role hypothesis: Product Manager - Consumer Nutrition, Product Manager - D2C / Quick Commerce, Associate Product Manager - Growth.

Fit thesis: Consumer health-adjacent D2C with clean-label positioning overlaps Deepansh's healthtech background and consumer psychology training. Growth channel expansion (digital + quick-commerce) maps to funnel and acquisition work.

Proof points:

  • HealthPlix consumer-facing features (Google Review Link — 75% win-back rate from competitors).
  • Refer-and-earn growth loop design with measurable lead quality improvement.

Entry path:

  1. Check The Func. Lab website / LinkedIn for hiring signals.
  2. Search LinkedIn for founders/leadership at The Func. Lab.
  3. Suggested outreach angle: health-adjacent consumer PM with D2C growth experience.

Outreach draft:

Hi — congrats on The Func. Lab's seed round. I'm a PM with healthtech (HealthPlix) and consumer growth experience — clean-label functional nutrition across quick-commerce is a product space I'd love to build in. Would explore PM or growth product roles as you scale distribution.

Risk flags: Very early stage ($1.5M seed). May not hire PM for several quarters. Small team likely founder-led product.


8. Spense

Funding: $2.8M Seed — 1 Jul 2026
Source: https://inc42.com/buzz/spense-raises-2-8-mn-from-arkam-ventures-to-build-secured-lending-infra/
Score: 7.4/10 — fintech SaaS infrastructure; Razorpay Ventures backing.

What they do:

  • Fintech SaaS enabling banks to launch asset-backed credit products (secured credit cards, credit lines) without replacing core banking infrastructure.
  • Arkam Ventures-led seed with Razorpay Ventures, GrowthCap Ventures, and Atrium Ventures; founded 2022.
  • Building modern credit infrastructure layer for Indian banks.

Why hiring now:

  • Seed capital to build secured lending infrastructure product; Razorpay Ventures participation signals payments/credit ecosystem integration needs.
  • Banks-as-customers B2B model requires product management for integration workflows.

Role hypothesis: Product Manager - Fintech Infrastructure, Product Manager - Bank Integrations, Associate Product Manager - Credit Products.

Fit thesis: B2B SaaS platform experience from HealthPlix applies to bank integration workflows. Less domain fit than healthtech but strong platform PM transferable skills.

Proof points:

  • Scaled B2B SaaS platform to 10,000+ users with cross-functional delivery of 100+ critical fixes.
  • Customized product for Government of Goa partnership — complex stakeholder integrations.

Entry path:

  1. Check Spense careers / LinkedIn jobs and Razorpay Ventures portfolio.
  2. Search LinkedIn for founders Pawan Kumar and Srinivas Krishnamurthy.
  3. Suggested outreach angle: B2B platform PM from regulated workflow SaaS background.

Outreach draft:

Hi — congrats on Spense's seed round with Arkam and Razorpay Ventures. I'm a B2B SaaS PM from HealthPlix experienced in complex integrations and workflow productisation for institutional customers. Would love to explore PM roles as you build secured lending infrastructure.

Risk flags: Early seed stage. Fintech infra may hire technical PMs with banking domain. No careers page verified.


9. Incuspaze

Funding: ₹150 Cr (~$15.9M) — 29 Jun 2026
Source: https://startup.economictimes.indiatimes.com/news/funding-deals/incuspaze-raises-rs-150-crore-led-by-bharat-value-fund/132067232
Score: 7.2/10 — proptech/workplace SaaS; technology stack investment; FY29 IPO track.

What they do:

  • Gurugram managed workspace operator across 50 locations in 18 cities (4M+ sq ft); acquired iKeva, TRIOS, VSKOUT (real estate SaaS).
  • Bharat Value Fund-led round; capital for market expansion, technology stack, acquisitions, and FY29 IPO preparation.
  • Targeting ₹1,000 Cr revenue by FY29.

Why hiring now:

  • Explicit "strengthen technology stack" mandate plus VSKOUT SaaS acquisition suggests product/engineering investment.
  • IPO preparation typically formalises product and data functions.

Role hypothesis: Product Manager - Workplace Platform, Product Manager - Enterprise Solutions, Senior Product Manager - PropTech SaaS.

Fit thesis: B2B SaaS workflow and enterprise customer experience from HealthPlix transfers to managed workspace platform. Weaker health/consumer fit but solid B2B PM opportunity.

Proof points:

  • Scaled enterprise SaaS with high retention (>95%) across diverse user segments.
  • Customized workflows for government and enterprise partnerships.

Entry path:

  1. Check Incuspaze careers / LinkedIn jobs.
  2. Search LinkedIn for founder & CEO Sanjay Choudhary.
  3. Suggested outreach angle: B2B platform PM from high-retention SaaS scaling experience.

Outreach draft:

Hi Sanjay — congrats on Incuspaze's ₹150 Cr raise. I'm a B2B SaaS PM from HealthPlix with experience scaling platform adoption and enterprise workflows. Your technology stack investment ahead of FY29 IPO looks like a compelling product challenge — would love to explore PM roles.

Risk flags: PropTech/workplace less aligned with preferred sectors. IPO track may prioritise finance/ops. Stage may be beyond classic PM-hire window.


10. PlayBlue

Funding: $2.7M Seed — 2 Jul 2026
Source: https://economictimes.indiatimes.com/industry/services/retail/playblue-raises-2-7-million-in-seed-funding-to-expand-omnichannel-sports-retail-business/articleshow/132140939.cms
Score: 7.0/10 — consumer omnichannel retail; flagship store rollout; community-building ambition.

What they do:

  • Omnichannel multi-brand sports retail platform co-founded by sports industry veterans Satyam Trivedi and Jayam Vora.
  • Centre Court Capital and MIXI Global co-led seed with WEH Ventures.
  • Launching 15,000 sq ft Bengaluru flagship plus Mumbai and Delhi NCR stores; 150+ store / 10M user community vision over 5 years.

Why hiring now:

  • Seed funds first flagship stores and pan-India e-commerce platform launch.
  • Omnichannel rollout creates product problems across discovery, inventory, and community engagement.

Role hypothesis: Product Manager - Omnichannel Retail, Product Manager - Consumer App, Associate Product Manager - Community/Growth.

Fit thesis: Consumer marketplace and omnichannel experience from Next Workout side project and Tier 2–3 insight apply. Weaker healthtech alignment but solid consumer PM angle.

Proof points:

  • Next Workout: two-sided marketplace with 70+ screens and intent-based booking flows.
  • Field sales experience across Tier 2–3 geographies informing user setup and conversion behaviour.

Entry path:

  1. Check PlayBlue careers / LinkedIn jobs.
  2. Search LinkedIn for cofounders Satyam Trivedi and Jayam Vora.
  3. Suggested outreach angle: omnichannel consumer PM from marketplace research background.

Outreach draft:

Hi — congrats on PlayBlue's seed round. I'm a PM with consumer marketplace product work and Tier 2–3 India user insight from field sales. Your omnichannel sports retail launch looks like an exciting product challenge — would love to explore PM roles as you build stores and community.

Risk flags: Retail-heavy; product may be ops-led early. Very ambitious 5-year targets. No verified PM posting.


Canada (5 companies)

Note: Only two verified Seed–Series B deals announced Mon 29 Jun – Sun 5 Jul in Canadian startup press (Stathera Series B, JUDI.AI growth round). Five entries below include two new in-window deals plus three watchlist carries with strongest remote-from-India signals from prior surfaced companies.

1. JUDI.AI

Funding: Growth round (amount undisclosed; CVC Fund #2 typically invests $500K–$3M) — 29 Jun 2026
Source: https://betakit.com/conexus-venture-capital-invests-in-fintech-judi-ai/
Remote from India: Partial signal — Vancouver HQ with explicit US market expansion and product development mandate; fintech SaaS may hire distributed product/engineering for AI platform, but no India-remote PM role verified.
Score: 7.8/10 — B2B fintech SaaS/AI; product development funding; weaker amount verification.

What they do:

  • Vancouver fintech providing AI-powered small-business lending automation for credit unions and community banks.
  • Conexus Venture Capital (Regina) investment via CVC Fund #2; Unitus Community Credit Union also participated.
  • Capital for US expansion, product development, customer service, and marketing.

Why hiring now:

  • Explicit product development and US market expansion funding.
  • Credit union ecosystem focus creates integration-heavy product roadmap.

Role hypothesis: Product Manager - Lending Platform, Product Manager - AI Workflows, Senior Product Manager - B2B Fintech.

Fit thesis: B2B workflow SaaS experience from HealthPlix maps to lending automation for institutional customers. AI agent/workflow productisation is adjacent to MyKare-style automation problems.

Proof points:

  • Shipped B2B workflows at scale with SQL/funnel analytics and cross-functional delivery.
  • Government partnership customization — complex stakeholder product requirements.

Entry path:

  1. Check JUDI.AI careers / LinkedIn jobs.
  2. Search LinkedIn for JUDI.AI leadership (founder referenced as "Baizley" in Techcouver coverage).
  3. Suggested outreach angle: B2B workflow PM exploring remote product roles for US expansion.

Outreach draft:

Hi — congrats on JUDI.AI's growth funding from Conexus VC. I'm a B2B SaaS PM from HealthPlix with workflow automation and analytics experience. Your AI lending platform and US expansion plans look compelling — would love to explore remote PM opportunities if you're open to India-based talent.

Risk flags: Funding amount not disclosed — may be below $1M minimum (fund range $500K–$3M). Remote-from-India not verified. Small credit-union-focused market.


2. Stathera

Funding: $55M USD Series B — 30 Jun 2026
Source: https://betakit.com/stathera-raises-55-million-usd-for-semiconductor-clock-tech-amid-data-centre-boom/
Remote from India: Unlikely — Montréal fabless semiconductor company scaling GEN2 production and opening Silicon Valley office; hardware/deep-tech hiring expected on-site.
Score: 6.5/10 — large round but poor PM/remote fit for Deepansh.

What they do:

  • Montréal fabless semiconductor company building MEMS-based precision timing chips for AI data centers, mobile, and IoT.
  • Maverick Silicon-led Series B with Celesta Capital, BDC Capital, MediaTek Innovation Fund, and others; $75M total raised.
  • Scaling GEN2 mass production; GEN3 AI data center platform targeting 2028 samples; Silicon Valley office planned.

Why hiring now:

  • Series B explicitly funds engineering and commercial team expansion plus Silicon Valley customer engagement.
  • 50→100+ headcount growth at Dominion-comparable scale signals hiring wave.

Role hypothesis: Product Manager - Semiconductor Platform (if hired), Technical Product Manager, Program Manager - Customer Integrations.

Fit thesis: Weak direct fit — deeptech hardware vs Deepansh's health/consumer SaaS strengths. Included because it is the largest verified Canada in-window deal; B2B customer integration PM skills transfer at the margins.

Proof points:

  • Cross-functional B2B platform delivery in complex technical environments.
  • Investor-facing product narrative during fundraising.

Entry path:

  1. Check Stathera careers / LinkedIn jobs (Montréal + upcoming Silicon Valley).
  2. Search LinkedIn for cofounder & CEO George Xereas.
  3. Suggested outreach angle: only if remote product roles emerge for platform/customer-facing surfaces.

Outreach draft:

Hi George — congrats on Stathera's $55M Series B. I'm a B2B SaaS PM — curious whether product roles may open as you scale customer engagement, though I understand hardware R&D may dominate hiring.

Risk flags: Fails remote-from-India filter. Deeptech semiconductor. PM roles likely require hardware domain expertise.


3. Scispot (watchlist carry — funding outside this window)

Funding: $8M USD Series A — 4 Jun 2026 (outside Jun 29–Jul 5 window)
Source: https://betakit.com/scispot-closes-8-million-usd-series-a-to-become-the-operating-layer-for-life-sciences-labs/
Remote from India: Partial signal — prior digest noted Belagavi product marketing role; Ontario-remote PM not verified.
Score: 7.9/10 — still strongest ongoing Canada healthtech SaaS pick despite stale funding date.

What they do:

  • AI-native operating layer for life sciences labs (Kitchener-Waterloo HQ).
  • Avenue Growth Partners-led Series A; forward-deployed AI engineers model.

Why hiring now:

  • Series A capital adds product, engineering, AI, implementation, and customer success roles in Canada.

Role hypothesis: Product Manager - Lab Operations, Senior Product Manager - Life Sciences SaaS.

Fit thesis: HealthPlix B2B clinical workflow overlap remains strong; included as watchlist carry because no new in-window Canada healthtech deal matched Scispot's profile.

Proof points:

  • Scaled clinician-facing workflows; 0-to-1 specialty launch with conversion impact.

Entry path:

  1. Re-check Scispot careers for India-eligible or remote PM roles.

Outreach draft:

Hi — I'm revisiting Scispot after your Series A. HealthPlix PM background in high-trust clinical workflows — would love to explore PM roles if India-remote is possible.

Risk flags: Funding outside coverage window. Remote-from-India not confirmed for PM titles.


4. Tetrix (watchlist carry — funding outside this window)

Funding: $15M USD Series A — 23 Jun 2026 (outside Jun 29–Jul 5 window)
Source: https://betakit.com/tetrix-raises-15-million-usd-to-excavate-investor-data-buried-in-old-technolgies/
Remote from India: Plausible but unverified — Canadian co-founded; headcount in Montréal and NYC; no India-specific role confirmed.
Score: 7.7/10 — B2B SaaS/AI workflow fit; best cross-border signal among surfaced Canada companies.

What they do:

  • AI investment intelligence platform extracting structured data from PDFs, emails, and legacy LP documents.
  • White Star Capital and Innovation Endeavors co-led Series A; serves institutional investors globally.

Why hiring now:

  • Series A funds product development and team expansion in Montréal and NYC.

Role hypothesis: Product Manager - AI Data Platform, Senior Product Manager - Enterprise Workflows.

Fit thesis: B2B SaaS workflow and analytics experience from HealthPlix translates to unstructured-data product problems.

Proof points:

  • SQL/Mixpanel funnel work; roadmap reprioritisation from behavioural data.

Entry path:

  1. Re-check Tetrix careers / LinkedIn jobs for remote-friendly PM roles.

Outreach draft:

Hi — congrats on Tetrix's Series A. I'm a B2B SaaS PM from HealthPlix with analytics and workflow product experience — would explore PM roles if remote-from-India is possible.

Risk flags: Already surfaced 2026-06-29. Funding outside coverage window. Remote not verified.


5. Lexful (watchlist carry — funding outside this window)

Funding: $7M USD Seed — 11 Jun 2026 (outside Jun 29–Jul 5 window)
Source: https://betakit.com/lexful-raises-7-million-usd-to-replace-spreadsheets-for-security-teams/
Remote from India: Partial signal — remote-first security SaaS startup; prior coverage noted distributed team model, but India-specific PM hiring not verified.
Score: 7.5/10 — B2B SaaS workflow fit; remote-first culture is strongest carry-over signal.

What they do:

  • Remote-first SaaS replacing spreadsheets for security teams with collaborative workflow platform.
  • Inovia Capital-led seed; Canadian startup targeting global security operations market.

Why hiring now:

  • Seed capital for product and go-to-market; remote-first model may extend hiring geography.

Role hypothesis: Product Manager - Security Workflows, Senior Product Manager - B2B SaaS.

Fit thesis: B2B workflow SaaS shipping experience transfers; remote-first culture is most plausible Canada path for India-based PM.

Proof points:

  • HealthPlix B2B platform scaling with high retention and cross-functional delivery.

Entry path:

  1. Re-check Lexful careers for remote PM roles open to India.

Outreach draft:

Hi — I'm revisiting Lexful after your seed round. B2B SaaS PM from HealthPlix — would love to explore remote PM roles if you're hiring across time zones.

Risk flags: Already surfaced 2026-06-20. Funding outside coverage window. Security domain may require specialised knowledge.


Skipped / watchlist

CompanyCountryReason skipped
Dominion DynamicsCanada$139M Series A — 30 Jun 2026; already surfaced 2026-06-21; defence hardware; fails remote-from-India filter
Wafr TechnologiesCanada$100M toward $300M goal — 2 Jul 2026; stage not Seed/A/B (fundraising campaign tranche); infrastructure/datacenter ops
Float FinancialCanada$85M Series C — outside Seed/A/B stage filter
Limelight DiamondsIndiaRs 275 Cr strategic round — lab-grown diamonds; stage/type unclear vs Seed/A/B filter
NinjacartIndia$6M partial tranche — part of larger round; agritech ops; weak PM fit
BatX EnergiesIndia$11M Series A cleantech/B2B battery recycling — valid funding but ranked below top 10 for PM fit
Dovetail CapitalIndia$10.5M Series A fintech asset servicing — B2B infra; weaker consumer/health alignment
BCT VenturesIndia$4.4M Seed ecommerce enablers — below top 10 rank
Tulon MaterialsIndia$1.1M Seed manufacturing — borderline amount; B2B manufacturing weak PM fit
Albatross EnergeticsIndia$1.1M IoT/hardware — below preference sectors
Mykare $1M trancheIndiaIncluded as part of MyKare.ai entry (total $3.2M)
CRED / late-stageIndiaNo in-window Seed/A/B deals skipped for stage

Dominion Dynamics note: Record $139M Series A announced 30 Jun — team scaling 50→100+. Already in pipeline; no new PM posting verified this week. Revisit if product leadership roles appear on careers page.

Canada week summary: JUDI.AI is the only new in-window deal with plausible (unverified) remote product hiring signal. Stathera is the largest cheque but unlikely to hire India-remote PMs. Scispot, Tetrix, and Lexful remain best watchlist targets from prior weeks.